Skip to main content

and
Your search also matched 7 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Role of m6A modifications in immune evasion and immunotherapy

Include preview-only content
  1. Article

    Open Access

    Plasma ctDNA enhances the tissue-based detection of oncodriver mutations in colorectal cancer

    The advent of circulating tumor DNA (ctDNA) technology has provided a convenient and noninvasive means to continuously monitor cancer genomic data, facilitating personalized cancer treatment. This study aimed ...

    Wei Wang, Yisen Huang, Jianqiao Kong, Lin Lu in Clinical and Translational Oncology (2024)

  2. Article

    Open Access

    Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study

    This prospective multicenter phase II study evaluated the clinical efficacy of neoadjuvant nivolumab-exclusive (N) and nivolumab–chemotherapy (N/C) combinations based on PD-L1 expression. Eligible patients exh...

    Si-Yang Liu, Song Dong, Xue-Ning Yang in Signal Transduction and Targeted Therapy (2023)

  3. Article

    Open Access

    Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial

    EMERGING-CTONG 1103 showed improved progression-free survival (PFS) with neoadjuvant erlotinib vs. chemotherapy for patients harbouring EGFR sensibility mutations and R0 resected stage IIIA-N2 non-small cell l...

    Wen-Zhao Zhong, Hong-Hong Yan, Ke-Neng Chen in Signal Transduction and Targeted Therapy (2023)

  4. Article

    Open Access

    SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway

    Ovarian cancer is the seventh most common cancer in women, and it causes many deaths in women worldwide. Patients with ovarian cancer have a poor prognosis and low survival rate. This study aimed to explore th...

    Ying Wang, **a Luo, Nayiyuan Wu, Qian** Liao, **g Wang in Medical Oncology (2023)

  5. Article

    Open Access

    The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity

    Cancer metabolic reprogramming enhances its malignant behaviors and drug resistance, which is regulated by POU domain transcription factors. This study explored the effect of POU domain class 2 transcription f...

    **guan Lin, Longzheng **a, Linda Oyang, Jiaxin Liang, Shiming Tan, Nayiyuan Wu in Oncogene (2022)

  6. Article

    Open Access

    Long non-coding RNA AFAP1-AS1 accelerates lung cancer cells migration and invasion by interacting with SNIP1 to upregulate c-Myc

    Actin filament associated protein 1 antisense RNA 1 (named AFAP1-AS1) is a long non-coding RNA and overexpressed in many cancers. This study aimed to identify the role and mechanism of AFAP1-AS1 in lung cancer...

    Yu Zhong, Liting Yang, Fang **ong, Yi He in Signal Transduction and Targeted Therapy (2021)

  7. Article

    Open Access

    LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma

    Long-palate, lung and nasal epithelium clone 1 (LPLUNC1) is a tumour suppressor gene in nasopharyngeal carcinoma (NPC), and low expression of LPLUNC1 is associated with poor prognosis. Our previous study showe...

    Heran Wang, Yujuan Zhou, Linda Oyang, Yaqian Han, Longzheng **a, **gguan Lin in Oncogene (2019)

  8. Article

    Open Access

    Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications

    Esophageal cancer (EC) is the sixth leading cause of cancer-related death worldwide. The lack of early diagnostic biomarkers and effective prognostic indicators for metastasis and recurrence has resulted in th...

    Min Su, Yuhang **ao, Junliang Ma, Deliang Cao in Journal of Hematology & Oncology (2018)